GoodRx Holdings, Inc. Federal Income Tax Expense (Benefit), Continuing Operations
GoodRx Holdings, Inc. (GDRX) reported Federal Income Tax Expense (Benefit), Continuing Operations of $21.90 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations · last filed 2026-02-26
- GoodRx Holdings, Inc. federal income tax expense (benefit), continuing operations for fiscal 2025 was $21.90M, a 59.38% increase from fiscal 2024.
- GoodRx Holdings, Inc. federal income tax expense (benefit), continuing operations for fiscal 2024 was $13.74M.
- GoodRx Holdings, Inc. federal income tax expense (benefit), continuing operations for fiscal 2023 was -$25.27M.
| Period end | Federal Income Tax Expense (Benefit), Continuing Operations 12 month |
|---|---|
| 2025-12-31 | $21.90M 10-K · filed 2026-02-26 |
| 2024-12-31 | $13.74M 10-K · filed 2026-02-26 |
| 2023-12-31 | -$25.27M 10-K · filed 2026-02-26 |